Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Actas Urologicas Espanolas|January 27, 2015
Is there a limit for the laparoscopic approach of a retroperitoneal residual mass postchemotherapy?J M Gaya, J Palou, J A Peña, et al.
Urologia Internationalis|November 28, 2013
Predictive factors for impaired renal function following nephroureterectomy in upper urinary tract urothelial cell carcinomaO Rodríguez Faba, J Palou, A Breda, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2011
Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapyGerald Hj Mickisch, Björn Schwander, Bernard Escudier, et al.
Medical Oncology (Northwood, London, England)|July 8, 2011
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreementC Porta, G Tortora, C Linassier, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 1, 2011
Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in SpainE Calvo Aller, P Maroto, N Kreif, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 30, 2001
Fungal infections in patients with solid tumors treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantationJ Montesinos, C Sola, P Maroto, et al.
Pageof 6